| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.03 | 0.5 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.039 | 0.5 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | -0.031 | 0.5 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.5 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | -0.036 | 0.5 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | 0.023 | 0.5 |